Clinical Trial Update: Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating total neoadjuvant therapy including a PD-1 inhibitor for locally advanced rectal cancer is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: The First Affiliated Hospital of University of Science and Technology of China | Conditions: Rectal Cancer Patients | Phase 2 | Status: NOT_YET_RECRUITING